Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17805
Corporate User License Price USD 750
Corporate User License Price INR 53415
Site License Price USD 500
Site License Price INR 35610
Request a Quote

Report Title

Oxford Pharmascience Group Plc (ABA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Oxford Pharmascience Group Plc (ABA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Oxford Pharmascience Group Plc (ABA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Oxford Pharmascience Group Plc (ABA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Oxford Pharmascience Group Plc (Oxford Pharmascience) is a drug development company that develops improved formulations of non-steroidal anti-inflammatory drugs and statins. The company offers products such as reduced gastric irritation taste masked ibuprofen, reduced gastric irritation taste masked naxproxen, reduced gastric irritation taste masked diclofenac, and others. It provides products such as reduced gastric irritation taste masked aspirin, and atrovastatin with higher efficacy and improved tolerance. Oxford Pharmascience develops drugs for the treatment of pain relief and cardiovascular diseases. The company also offers calcium and vitamin D chews. The company distributes its products in the UK and Brazil. Oxford Pharmascience is headquartered in London, the UK.

Oxford Pharmascience Group Plc (ABA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Oxford Pharmascience Enters Into Agreement With Healthcare Company To Develop Dietary Supplement Product 10

Licensing Agreements 11

Oxford Pharmascience Extends Licensing Agreement With UCL Business 11

Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology 12

Oxford Pharmascience Enters Into Licensing Agreement With Bayer Consumer Care 13

Oxford Pharmascience Enters Into Licensing Agreement With Hermes Pharma 14

Equity Offering 15

Oxford Pharmascience to Raise USD30 Million in Private Placement of Shares 15

Oxford Pharmascience Completes Private Placement Of Shares For USD 6.4 Million 17

Oxford Pharmascience Completes Private Placement Of Shares For USD 7.6 Million 18

Oxford Pharmascience Completes Private Placement Of Shares For USD 3 Million 19

Oxford Pharmascience Group Plc-Key Competitors 20

Oxford Pharmascience Group Plc-Key Employees 21

Oxford Pharmascience Group Plc-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

Financial Announcements 23

Sep 25, 2017: Oxford Pharmascience Group: Interim results for the six months to 30 June 2016 23

Mar 10, 2017: Oxford Pharmascience: Final Results for the year ended 31 December 2016 24

Government and Public Interest 25

Jun 08, 2017: Oxford Pharmascience Group Provides Further Update Regarding OXPzero Ibuprofen Programmes 25

Other Significant Developments 27

Jan 17, 2017: Oxford Pharmascience Group: Technical, Clinical and Regulatory Update 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

List of Tables

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Oxford Pharmascience Group Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Oxford Pharmascience Group Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Oxford Pharmascience Enters Into Agreement With Healthcare Company To Develop Dietary Supplement Product 10

Oxford Pharmascience Extends Licensing Agreement With UCL Business 11

Oxford Pharmascience Enters Into Licensing Agreement With UCL Business For Drug Delivery Technology 12

Oxford Pharmascience Enters Into Licensing Agreement With Bayer Consumer Care 13

Oxford Pharmascience Enters Into Licensing Agreement With Hermes Pharma 14

Oxford Pharmascience to Raise USD30 Million in Private Placement of Shares 15

Oxford Pharmascience Completes Private Placement Of Shares For USD 6.4 Million 17

Oxford Pharmascience Completes Private Placement Of Shares For USD 7.6 Million 18

Oxford Pharmascience Completes Private Placement Of Shares For USD 3 Million 19

Oxford Pharmascience Group Plc, Key Competitors 20

Oxford Pharmascience Group Plc, Key Employees 21

Oxford Pharmascience Group Plc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Oxford Pharmascience Group Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person